EUVIMEDEUVIMED entdecken
Crossref

[18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer

Paulina Cegla, Geoffrey Currie, Joanna P Wroblewska, Joanna Kazmierska, Witold Cholewinski, Inga Jagiello, Krzysztof Matuszewski, Andrzej Marszalek, Anna Kubiak, Pawel Golusinski, Wojciech Golusinski, Ewa Majchrzak

Nuklearmedizin - NuclearMedicine · 2025-03 · 64 (01) · 22-31

DOI: 10.1055/a-2365-7808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, online erschienen am 04.12.2024. Verfasst von Paulina Cegla und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, Greater Poland Cancer Centre, Poznan, Poland. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Head and Neck Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Greater Poland Cancer Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To determine whether [18F]FDG PET/CT and hematological parameters provide supportive data to determine HPV status in HNSCC patients. Retrospective analysis of clinical and diagnostic data from 106 patients with HNSCC: 26.4% HPV-positive and 73.6% HPV-negative was performed. The following semiquantitative PET/CT parameters for the primary tumor and hottest lymph node and liver were evaluated: SUVmax, SUVmean, TotalSUV, MTV, TLG, maximum, mean and TLG tumor-to-liver ratio (TLRmax, TLRmean,TLRTLG) and heterogeneity index (HI). Following hematological variables were assessed: white blood cell (WBC); lymphocyte (LYMPH); neutrophil (NEU),monocyte (MON); platelet (PLT); neutrophil-to-lymphocyte ratio (NRL); lymphocyte-to-monocyte ratio (LMR); platelet-to lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR). Conventional statistical analyses were performed in parallel with an artificial neural network analysis (Neural Analyzer, v. 2.9.5). Significant between-group differences were observed for two of the semiquantitative PET/CT parameters, with higher values in the HPV-negative group: primary tumor MTV (22.2 vs 9.65; p=0.023), and TLRmax (3.50 vs 2.46; p=0.05). The HPV-negative group also had a significantly higher NEU count (4.84 vs. 6.04; p=0.04), NEU% (58.2 vs. 66.2; p=0.007), and NRL% (2.69 vs. 3.94; p=0.038). Based on ROC analysis (sensitivity 50%, specificity 80%, AUC 0.5), the following variables were independent predictors of HPV-negativity: primary tumor with SUVmax >10; TotalSUV >2800; MTV >23.5; TLG >180; TLRmax >3.7; TLRTLG >5.7; and oropharyngeal localization. Several semiquantitative parameters derived from [18F]FDG PET/CT imaging of the primary tumor (SUVmax, TotalSUV, MTV, TLG, TLRmax and TLRTLG) were independent predictors of HPV-negativity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyHead and Neck NeoplasmsPapillomavirus InfectionsHumansMaleFemaleMiddle AgedAgedRadiopharmaceuticalsSensitivity and SpecificityAdultReproducibility of ResultsRetrospective StudiesAged, 80 and over

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Nuclear Medicine Department, Greater Poland Cancer Centre, Poznan, Poland.
  • School of Dentistry and Health Sciences, Charles Sturt University, Wagga Wagga, Australia.
  • Department of Oncologic Pathology and Prophylaxis, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Tumor Pathology, Greater Poland Cancer Centre, Poznan, Poland.
  • Department of Electroradiology, Poznan University of Medical Sciences, Poznan, Poland.
  • 2nd Radiotherapy Department, Greater Poland Cancer Centre, Poznan, Poland.

Förderung

  • Greater Poland Cancer Centre

Zitieren

APA

Cegla, P., Currie, G., Wroblewska, J. P., Kazmierska, J., Cholewinski, W., Jagiello, I., Matuszewski, K., Marszalek, A., Kubiak, A., Golusinski, P., Golusinski, W., & Majchrzak, E. (2025). [18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer. Nuklearmedizin - NuclearMedicine, 64(01), 22-31. https://doi.org/10.1055/a-2365-7808

Vancouver

Cegla P, Currie G, Wroblewska JP, Kazmierska J, Cholewinski W, Jagiello I, et al. [18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer. Nuklearmedizin - NuclearMedicine. 2025;64(01):22-31. doi:10.1055/a-2365-7808

BibTeX
@article{Cegla2025,
  author = {Cegla, Paulina and Currie, Geoffrey and Wroblewska, Joanna P and Kazmierska, Joanna and Cholewinski, Witold and Jagiello, Inga and Matuszewski, Krzysztof and Marszalek, Andrzej and Kubiak, Anna and Golusinski, Pawel and Golusinski, Wojciech and Majchrzak, Ewa},
  title = {[18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2025},
  volume = {64},
  number = {01},
  pages = {22--31},
  doi = {10.1055/a-2365-7808}
}
Kostenlos starten →